Clinical Research Directory

Inclusion Criteria: * At least 3 years have elapsed since esophagectomy due to esophageal cancer * Provide signed informed consent Exclusion Criteria: * Current use of the following osteoporosis agents; Teriparatide, Denosumab, and - - * bisphosphonate * Present malignancy (except in situ carcinoma) * Radiotherapy * Any condition that required chronic (greater than three months cumulative and greater than 5 mg/day) glucocorticoid therapy * Other diseases which affect bone metabolism Any disorder that, in the opinion of the investigator, may compromise the ability of the subject to give written informed consent and/or comply with study procedures Received \> 3 months (or equivalent) of osteoporosis treatment Currently enrolled in or has not yet completed at least 1 month since ending other investigational device or drug trial(s), or subject is receiving other investigational agent(s).